The role of recombination for the coevolutionary dynamics of HIV and the immune response

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Mostowy, Rafal ^a   Kouyos, Roger D ^a   Fouchet, David ^b   Bonhoeffer, Sebastian ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA SHUFFLING; EFFECTOR CELL; EVOLUTIONARY ADAPTATION; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MATHEMATICAL MODEL; MICROBIAL POPULATION DYNAMICS; MOLECULAR EVOLUTION; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; VIRUS LOAD; VIRUS MORPHOGENESIS; VIRUS MUTATION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; ADAPTIVE IMMUNITY; ANTIGENIC VARIATION; BIOLOGICAL MODEL; COMPUTER SIMULATION; GENETIC RECOMBINATION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE EVASION; IMMUNOLOGY; MUTATION; PHYSIOLOGY; THEORETICAL MODEL; TIME; VIROLOGY;

ADAPTIVE IMMUNITY; ANTIGENIC VARIATION; COMPUTER SIMULATION; EVOLUTION, MOLECULAR; GENETIC VARIATION; HIV; HIV INFECTIONS; HUMANS; IMMUNE EVASION; MODELS, BIOLOGICAL; MODELS, THEORETICAL; MUTATION; RECOMBINATION, GENETIC; TIME FACTORS;

EID: 79951974746     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016052     Document Type: Article

References (71)

1. Onafuwa-Nuga A, Telesnitsky A, (2009) The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev 73: 451-480.
2. Robertson DL, Sharp PM, McCutchan FE, Hahn BH, (1995) Recombination in HIV-1. Nature 374: 124.
3. Wooley DP, Smith RA, Czajak S, Desrosiers RC, (1997) Direct demonstration of retroviral recombination in a rhesus monkey. J Virol 71: 9650.
4. An W, Telesnitsky A, (2002) HIV-1 genetic recombination: experimental approaches and observations. AIDS Rev 4: 195-212.
5. Chen J, Powell D, Hu WS, (2006) High frequency of genetic recombination is a common feature of primate lentivirus replication. J Virol 80: 9651-9658.
6. Kuwata T, Miyazaki Y, Igarashi T, Takehisa J, Hayami M, (1997) The rapid spread of recombinants during a natural in vitro infection with two human immunodeficiency virus type 1 strains. J Virol 71: 7088-7091.
7. Rhodes T, Wargo H, Hu WS, (2003) High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J Virol 77: 11193-11200.
8. Gratton S, Cheynier R, Dumaurier MJ, Oksenhendler E, Wain-Hobson S, (2000) Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc Nat Acad Sci 97: 14566-14571.
9. Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, et al. (2002) Recombination: multiply infected spleen cells in HIV patients. Nature 418: 144.
10. Quiñones-Mateu ME, Arts EJ, (1999) Recombination in HIV-1: update and implications. Aids Rev 1: 89-100.
11. Althaus CL, Bonhoeffer S, (2005) Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1. J Virol 79: 13572.
12. Bonhoeffer S, Chappey C, Parkin NT, Whitcomb JM, Petropoulos CJ, (2004) Evidence for positive epistasis in HIV-1. Science 306: 1547.
13. Fraser C, (2005) HIV recombination: what is the impact on antiretroviral therapy? J R Soc Interface 2: 489.
14. Kouyos RD, Fouchet D, Bonhoeffer S, (2009) Recombination and drug resistance in HIV: Population dynamics and stochasticity. Epidemics 1: 58-69.
15. Moutouh L, Corbeil J, Richman DD, (1996) Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Nat Acad Sci 93: 6106-6111.
16. Vijay NNV, Ajmani R, Perelson AS, Dixit NM, (2008) Recombination increases human immunodeficiency virus fitness, but not necessarily diversity. J Gen Virol 89: 1467.
17. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, et al. (1997) Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3: 205-211.
18. Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, et al. (2004) Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med 199: 905-915.
19. Jones N, Wei X, Flower D, Wong M, Michor F, et al. (2004) Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med 200: 1243.
20. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, et al. (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453-459.
21. Goulder PJR, Watkins DI, (2004) HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 4: 630-640.
22. Lopez M, Soriano V, Benito JM, (2007) Escape Mutations in HIV Infection and its Impact on CD8 T Cell Responses. Curr Mol Med 7: 446-458.
23. Fernandez CS, Stratov I, De Rose R, Walsh K, Dale CJ, et al. (2005) Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J Virol 79: 5721-5731.
24. Liu Y, McNevin J, Zhao H, Tebit DM, Troyer RM, et al. (2007) Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. J Virol 81: 12179-12188.
25. Friedrich TC, Frye CA, Yant LJ, O'Connor DH, Kriewaldt NA, et al. (2004) Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. J Virol 78: 2581.
26. Kelleher AD, Long C, Holmes EC, Allen RL, Wilson J, et al. (2001) Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 193: 375-386.
27. Hamilton WD, Axelrod R, Tanese R, (1990) Sexual Reproduction as an Adaptation to Resist Parasites (A Review). Proc Nat Acad Sci 87: 3566-3573.
28. Otto SP, Nuismer SL, (2004) Species Interactions and the Evolution of Sex. Science 304: 1018-1020.
29. Salathé M, Kouyos RD, Bonhoeffer S, (2008) The state of affairs in the kingdom of the Red Queen. Trends Ecol Evol 23: 439-445.
30. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, et al. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126.
31. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, et al. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122.
32. Otto SP, Lenormand T, (2002) Resolving the paradox of sex and recombination. Nat Rev Gen 3: 252-261.
33. Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, et al. (1995) Antigenic Oscillations and Shifting Immunodominance in HIV-1 Infections. Nature 375: 606-611.
34. De Boer RJ, (2007) Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus. J Virol 81: 2838-2848.
35. Althaus CL, De Boer RJ, (2008) Dynamics of immune escape during HIV/SIV infection. PLoS Comput Biol 4: e1000103.
36. Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, et al. (1999) Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354: 1782-1785.
37. Müller V, Marée AF, De Boer RJ, (2001) Small variations in multiple parameters account for wide variations in HIV-1 set-points: a novel modelling approach. Proc Roy Soc B 268: 235-242.
38. Segel LA, (1988) On the validity of the steady state assumption of enzyme kinetics. Bull Math Biol 50: 579-593.
39. Graw F, Regoes RR, (2009) Investigating CTL Mediated Killing with a 3D Cellular Automaton. PLoS Comput Biol 5: e1000466.
40. Yates A, Graw F, Barber DL, Ahmed R, Regoes RR, et al. (2007) Revisiting estimates of CTL killing rates in vivo. PLoS One 2: e1301.
41. Charpentier C, Nora T, Tenaillon O, Clavel F, Hance AJ, (2006) Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J Virol 80: 2472-2482.
42. Bretscher MT, Althaus CL, Müller V, Bonhoeffer S, (2004) Recombination in HIV and the evolution of drug resistance: for better or for worse? Bioessays 26: 180-188.
43. Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, et al. (2004) Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol 78: 7069-7078.
44. Asquith B, Edwards CT, Lipsitch M, McLean AR, (2006) Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biology 4: e90.
45. Asquith B, McLean AR, (2007) In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques. Proc Nat Acad Sci 104: 6365-6370.
46. Mandl JN, Regoes RR, Garber DA, Feinberg MB, (2007) Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape. J Virol 81: 11982-11991.
47. O'Connor DH, McDermott AB, Krebs KC, Dodds EJ, Miller JE, et al. (2004) A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation. J Virol 78: 14012-14022.
48. Bonhoeffer S, Coffin JM, Nowak MA, (1997) Human immunodeficiency virus drug therapy and virus load. J Virol 71: 3275-3278.
49. Bonhoeffer S, Funk GA, Günthard HF, Fischer M, Müller V, (2003) Glancing behind virus load variation in HIV-1 infection. TRENDS Microbiol 11: 499-504.
50. Bell G, (1982) The Masterpiece of Nature: The Evolution and Genetics of Sexuality. Kluwer Academic Publishers.
51. Hamilton WD, (1976) Gamblers since life began: barnacles, aphids, elms. Quart Rev Biol 51: 407-412.
52. Jaenike J, (1978) An hypothesis to account for the maintenance of sex within populations. Evol Theory 3: 191-194.
53. Benaroch P, Billard E, Gaudin R, Schindler M, Jouve M, (2010) HIV-1 assembly in macrophages. Retrovirology 7.
54. Levy DN, Aldrovandi GM, Kutsch O, Shaw GM, (2004) Dynamics of HIV-1 recombination in its natural target cells. Proc Nat Acad Sci 101: 4204-4209.
55. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, et al. (1999) Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 5: 83-89.
56. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD, (1998) Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279: 1223-1227.
57. Stafford MA, Corey L, Cao Y, Daar ES, Ho DD, et al. (2000) Modeling plasma virus concentration during primary HIV infection. J Theor Biol 203: 285-301.
58. Petravic J, Ribeiro RM, Casimiro DR, Mattapallil JJ, Roederer M, et al. (2008) Estimating the Impact of Vaccination on Acute Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections. J Virol 82: 11589-11598.
59. Asquith B, Mosley AJ, Barfield A, Marshall SEF, Heaps A, et al. (2005) A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol 86: 1515-1523.
60. Regoes RR, Barber DL, Ahmed R, Antia R, (2007) Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc Nat Acad Sci 104: 1599-1603.
61. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, et al. (2003) A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol 77: 5037-5038.
62. Davenport MP, Ribeiro RM, Perelson AS, (2004) Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection. J Virol 78: 10096-10103.
63. Ogg GS, Jin X, Bonhoeffer S, Moss P, Nowak MA, et al. (1999) Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy. J Virol 73: 797-800.
64. Casazza JP, Betts MR, Picker LJ, Koup RA, (2001) Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy. J Virol 75: 6508-6516.
65. Butz EA, Bevan MJ, (1998) Massive expansion of antigen-specific CD8 T cells during an acute virus infection. Immunity 8: 167-175.
66. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, et al. (2003) Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77: 2081-2092.
67. Wang YE, Li B, Carlson JM, Streeck H, Gladden AD, et al. (2009) Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J Virol 83: 1845-1855.
68. Parera M, Fernàndez G, Clotet B, Martnez MA, (2007) HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol Biol Evol 24: 382.
69. Mansky LM, Temin HM, (1995) Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 69: 5087-5094.
70. Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, et al. (2000) High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol 74: 1234-1240.
71. Josefsson L, Palmer S, Casazza J, Ambrozak D, Kearney M, et al. (2010) Analysis of hiv dna molecules in paired peripheral blood and lymph node tissue samples from chronically infected patients. Antiviral Therapy 15 (Suppl).